By Katherine Hamilton
Staar Surgical plans to cut jobs this year in an attempt cut costs after it recorded a loss for the fourth quarter.
Operating expenses rose 12% last year primarily due to higher compensation-related expenses and increased headcount, Staar said Tuesday.
The eye surgery company posted a loss in the quarter of $34.2 million, or 69 cents a share, compared with a profit of $7.7 million, or 16 cents a share, in the year prior.
China, which is the largest market for refractive procedures, had fluctuating demand in 2024, lowering Staar's performance, the company said. Low demand and weak consumer sentiment in China is expected to continue in this year, especially during the first half, and the company is working on addressing elevated inventory levels there, Staar said.
Write to Katherine at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
February 11, 2025 16:28 ET (21:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。